Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including GARDASIL. Available dosage form: injection, suspension.
Drug Details
- Generic Name
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
- Brand Names
- GARDASIL
- Application Number
- BLA125126
- Sponsor
- Merck Sharp & Dohme LLC
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN